Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

 Actoplus Met (Pioglitazone HCI and Metformin HCI) Fixed-Dose Combination Tablets
Company: Takeda Global Research & Development Center
Application No.:  021842
Approval Date: 08/29/2005


Date created: January 222007

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.